Related content

N-of-1 trials: an opportunity to tailor treatment in individual patients

By Madhok Vishnu   Fahey Tom  

British Journal of General Practice, Vol. 55, Iss. 512, 2005-03 ,pp. : 172-172

Royal College of General Practitioners

Access to resources Recommend Favorite

Using n-of-1 trials as a clinical tool to improve prescribing

By Nikles C Jane   Clavarino Alexandra M.   Del Mar Chris B.  

British Journal of General Practice, Vol. 55, Iss. 512, 2005-03 ,pp. : 175-180

Royal College of General Practitioners

Access to resources Recommend Favorite

A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance

By Smith Brennan K.   Holloway Graham P.   Reza-Lopez Sandra   Jeram Stanley M.   Kang Jing X.   Ma David W.L.  

Applied Physiology, Nutrition, and Metabolism, Vol. 35, Iss. 5, 2010-10 ,pp. : 699-706

NRC Research Press

Access to resources Recommend Favorite

Synthesis and evaluation of p-N,N-dialkyl substituted chalcones as anti-cancer agents

By Nelson Grady   Alam Mohammad   Atkinson Tyler   Gurrapu Shirisha   Sravan Kumar J.   Bicknese Chris   Johnson Joseph   Williams Michael  

Medicinal Chemistry Research, Vol. 22, Iss. 10, 2013-10 ,pp. : 4610-4614

Springer Publishing Company

Access to resources Recommend Favorite

Structure-based design, synthesis, and anticonvulsant activity of isatin-1-N-phenylacetamide derivatives

By Xie Chao   Tang Li-Ming   Li Fu-Nan   Guan Li-Ping   Pan Cheng-Yan   Wang Si-Hong  

Medicinal Chemistry Research, Vol. 23, Iss. 5, 2014-05 ,pp. : 2161-2168

Springer Publishing Company

Access to resources Recommend Favorite